Literature DB >> 6619575

Epidemiology of rotaviruses in a cohort of 45 Guatamalan Mayan Indian children observed from birth to the age of three years.

L Mata, A Simhon, J J Urrutia, R A Kronmal, R Fernández, B García.   

Abstract

A cohort of 45 children was observed from birth to three years of age in their natural ecosystem to determine patterns of infection, morbidity, and growth. Data from enzyme-linked immunosorbent assay analysis for rotavirus of 5,891 extracts (kept frozen since 1964-1969) of weekly fecal specimens were compared against growth, morbidity, and specimen data files, permitting a retrospective description of the epidemiology of rotavirus infection in the cohort. Rotavirus infections were uncommon in the first months of life in intensively breast-fed infants. Infection increased with age to reach a maximal rate in the six- to 18-month age period. While there was a high incidence of diarrhea in the cohort, rotavirus was associated with only 10% of such episodes. The incidence of rotavirus infection was 1.2 episodes per child-year, and the incidence of rotavirus-associated diarrhea was 0.8 episodes per child-year. Serious outbreaks of rotavirus generally occurred from September through December, with as many as one-half of the children becoming infected. Repeated rotavirus infection was a common phenomenon.

Entities:  

Mesh:

Year:  1983        PMID: 6619575     DOI: 10.1093/infdis/148.3.452

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

2.  Adenovirus types 40 and 41 and rotaviruses associated with diarrhea in children from Guatemala.

Authors:  J R Cruz; P Cáceres; F Cano; J Flores; A Bartlett; B Torún
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

Review 3.  Development of rotavirus vaccines.

Authors:  R E Black; C Lanata
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

4.  Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections.

Authors:  Y Hoshino; R G Wyatt; J Flores; K Midthun; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

5.  Rotavirus vaccines--achievements and prospects.

Authors:  T H Flewett
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

6.  Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4.

Authors:  K Midthun; Y Hoshino; A Z Kapikian; R M Chanock
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

7.  Reinfection of adult cattle with rotavirus B during repeated outbreaks of epidemic diarrhea.

Authors:  Michiko Hayashi; Toshiaki Murakami; Yoshizumi Kuroda; Hikaru Takai; Hisahiro Ide; Ainani Awang; Tohru Suzuki; Ayako Miyazaki; Makoto Nagai; Hiroshi Tsunemitsu
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

8.  Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization.

Authors:  I de Zoysa; R G Feachem
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

9.  Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies.

Authors:  Joseph A Lewnard; Benjamin A Lopman; Umesh D Parashar; Naor Bar-Zeev; Prasanna Samuel; M Lourdes Guerrero; Guillermo M Ruiz-Palacios; Gagandeep Kang; Virginia E Pitzer
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

10.  Effects of maternal antibodies on protection and development of antibody responses to human rotavirus in gnotobiotic pigs.

Authors:  D C Hodgins; S Y Kang; L deArriba; V Parreño; L A Ward; L Yuan; T To; L J Saif
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.